Evaluation of the Relationship Between Polymorphisms in CYP2C19 and the Pharmacokinetics of Omeprazole, Pantoprazole and Rabeprazole

M Román, D Ochoa, SD Sánchez-Rojas… - …, 2014 - Taylor & Francis
Aim: To evaluate the possible association between polymorphisms in CYP2C19 and the
pharmacokinetics of omeprazole, rabeprazole and pantoprazole. Materials & methods: 151 …
被引用次数：39 相关文章

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole

M Román, D Ochoa, SD Sánchez-Rojas… - …, 2014 - pubmed.ncbi.nlm.nih.gov
Aim To evaluate the possible association between polymorphisms in CYP2C19 and the
pharmacokinetics of omeprazole, rabeprazole and pantoprazole. Materials & methods 151 …

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole.

M Román, D Ochoa, SD Sánchez-Rojas… - …, 2014 - europepmc.org
Evaluation of the relationship between polymorphisms in CYP2C19 and the
pharmacokinetics of omeprazole, pantoprazole and rabeprazole. - Abstract - Europe PMC …

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole

M Román, D Ochoa, SD Sánchez-Rojas… - …, 2014 - search.proquest.com
Aim: To evaluate the possible association between polymorphisms in CYP2C19 and the
pharmacokinetics of omeprazole, rabeprazole and pantoprazole. Materials & methods: 151 …

Evaluation of the relationship between polymorphisms in CYP2C19 and the pharmacokinetics of omeprazole, pantoprazole and rabeprazole

M Roman, D Ochoa, SD Sanchez-Rojas… - …, 2014 - go.gale.com
Background Proton-pump inhibitors (PPIs) are benzimidazole derivatives consisting of two
heterocyclic moieties linked via a methylsulfinyl group. These prodrugs cross the parietal …